Does ALEMTUZUMAB Cause Multiple sclerosis? 289 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 289 reports of Multiple sclerosis have been filed in association with ALEMTUZUMAB (Campath). This represents 2.0% of all adverse event reports for ALEMTUZUMAB.
289
Reports of Multiple sclerosis with ALEMTUZUMAB
2.0%
of all ALEMTUZUMAB reports
13
Deaths
116
Hospitalizations
How Dangerous Is Multiple sclerosis From ALEMTUZUMAB?
Of the 289 reports, 13 (4.5%) resulted in death, 116 (40.1%) required hospitalization, and 11 (3.8%) were considered life-threatening.
Is Multiple sclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 289 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Multiple sclerosis?
DIMETHYL (5,074)
NATALIZUMAB (4,078)
INTERFERON BETA-1A (3,412)
OCRELIZUMAB (2,609)
GLATIRAMER (2,596)
DALFAMPRIDINE (2,224)
FINGOLIMOD (2,123)
TERIFLUNOMIDE (1,983)
OFATUMUMAB (1,267)
DIROXIMEL (978)
Which ALEMTUZUMAB Alternatives Have Lower Multiple sclerosis Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET